Background: COVID-19 screening is an effective nonpharmaceutical intervention for identifying infected individuals and interrupting viral transmission. However, questions have been raised regarding its effectiveness in controlling the spread of novel variants and its high socioeconomic costs. Therefore, the optimization of COVID-19 screening strategies has attracted great attention. Objective: This review aims to summarize the evidence and provide a reference basis for the optimization of screening strategies for the prevention and control of COVID-19. Methods: We applied a methodological framework for scoping reviews and the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) checklist. We conducted a scoping review of the present publications on the optimization of COVID-19 screening strategies. We searched the PubMed, Web of Science, and Elsevier ScienceDirect databases for publications up to December 31, 2022. English publications related to screening and testing strategies for COVID-19 were included. A data-charting form, jointly developed by 2 reviewers, was used for data extraction according to the optimization directions of the screening strategies. Results: A total of 2770 unique publications were retrieved from the database search, and 95 abstracts were retained for full-text review. There were 62 studies included in the final review. We summarized the results in 4 major aspects: the screening population (people at various risk conditions such as different regions and occupations; 12/62, 19%), the timing of screening (when the target population is tested before travel or during an outbreak; 12/62, 19%), the frequency of screening (appropriate frequencies for outbreak prevention, outbreak response, or community transmission control; 6/62, 10%), and the screening and detection procedure (the choice of individual or pooled detection and optimization of the pooling approach; 35/62, 56%). Conclusions: This review reveals gaps in the optimization of COVID-19 screening strategies and suggests that a number of factors such as prevalence, screening accuracy, effective allocation of resources, and feasibility of strategies should be carefully considered in the development of future screening strategies.
1 January 2025 in Transboundary and Emerging Diseases
Background: Brucellosis epidemics in Yunnan Province in southern China have increased and caused more impact in recent years. However, the epidemiological characteristics and driving factors for brucellosis have not been clearly described. The aim of this study was to analyze the spatiotemporal distribution and potential factors for human brucellosis (HB) in Yunnan Province, 2006–2021. Methods: HB data were obtained from the China National Notifiable Infectious Diseases Reporting Information System. Global spatial autocorrelation and spatial scanning statistics were used to analyze the spatial patterns of brucellosis. Zero‐inflated negative binomial (ZINB) Bayesian spatiotemporal models were applied to the analysis of potential risk factors, including environmental, meteorological, and socioeconomic factors. Findings: Between 2006 and 2021, a total of 2794 brucellosis cases were reported. The central and western regions were the most severely affected. GDP showed a positive correlation with brucellosis risk when in the range 0–30.9 billion RMB, peaking with a relative risk (RR) of 13.64 (95% Bayesian credible interval [BCI]: 4.10, 49.10) at around 2.3 billion RMB. Conversely, a negative correlation was observed for GDP between 101 and 135 billion RMB, with the RR dropping to 0.14 (95% BCI: 0.01, 0.89) at 135 billion RMB. Brucellosis cases increased by 4.90% (95% BCI: 1.82%, 7.95%) per 1°C increase in temperature, while a 1° increase in slope reduced cases by 17.06% (95% BCI: 4.01%, 28.81%). Interpretation: Our findings suggest that socioeconomic factors play the greatest role in the occurrence of brucellosis in both northern and southern China; however, the effects of the environmental factors may be different between these areas. Differences in factors affecting each region need to be fully considered, and brucellosis prevention and control need to be adapted to these differences.
BACKGROUND COVID-19 screening is an effective nonpharmaceutical intervention for identifying infected individuals and interrupting viral transmission. However, questions have been raised regarding its effectiveness in controlling the spread of novel variants and its high socioeconomic costs. Therefore, the optimization of COVID-19 screening strategies has attracted great attention. OBJECTIVE This review aims to summarize the evidence and provide a reference basis for the optimization of screening strategies for the prevention and control of COVID-19. METHODS We applied a methodological framework for scoping reviews and the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) checklist. We conducted a scoping review of the present publications on the optimization of COVID-19 screening strategies. We searched the PubMed, Web of Science, and Elsevier ScienceDirect databases for publications up to December 31, 2022. English publications related to screening and testing strategies for COVID-19 were included. A data-charting form, jointly developed by 2 reviewers, was used for data extraction according to the optimization directions of the screening strategies. RESULTS A total of 2770 unique publications were retrieved from the database search, and 95 abstracts were retained for full-text review. There were 62 studies included in the final review. We summarized the results in 4 major aspects: the screening population (people at various risk conditions such as different regions and occupations; 12/62, 19%), the timing of screening (when the target population is tested before travel or during an outbreak; 12/62, 19%), the frequency of screening (appropriate frequencies for outbreak prevention, outbreak response, or community transmission control; 6/62, 10%), and the screening and detection procedure (the choice of individual or pooled detection and optimization of the pooling approach; 35/62, 56%). CONCLUSIONS This review reveals gaps in the optimization of COVID-19 screening strategies and suggests that a number of factors such as prevalence, screening accuracy, effective allocation of resources, and feasibility of strategies should be carefully considered in the development of future screening strategies.